 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 May 1998 | Volume 128 Issue 10 | Pages 848-856
In recent years, it has become apparent that overproduction of the Th1 cytokines interleukin-12 and interferon-
Author and Article Information
An edited summary of a Clinical Staff Conference held on 25 January 1997 at the National Institutes of Health, Bethesda, Maryland.
NIH CONFERENCE
The Pathogenesis of Mucosal Inflammation in Murine Models of Inflammatory Bowel Disease and Crohn Disease
is the probable driving force behind murine models of intestinal inflammation resembling Crohn disease and intestinal inflammation in humans with Crohn disease. In addition, studies of murine models strongly suggest that this overproduction is associated with inadequate secretion of the counter-regulatory and anti-inflammatory cytokine transforming growth factor-ß. Thus, mucosal inflammation in models (and possibly in humans) may result from an imbalance between normally occurring positive (immunogenic or inflammatory) responses and negative (tolerogenic or anti-inflammatory) mucosal immune responses. These new findings and the hypotheses that arise from them are being used to construct new approaches to the treatment of Crohn disease that are based on the administration of anti-inflammatory cytokines and anti-cytokine antibodies.
Authors who wish to cite a section of the conference and specifically indicate its author may use this example for the form of the reference:.
"Fuss IJ. Cytokine production in Crohn disease, pp 849-851. In: Strober W, moderator. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med. 1998; 128:848-856.".
Acknowledgments: The authors thank Drs. Rolf O. Ehrhardt, Markus F. Neurath, and Monica Boirivant for their vital role in this work and Nancy Shulman for editorial assistance.
Requests for Reprints: Warren Strober, MD, Chief, Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11N-238, Bethesda, MD 20892.
Current Author Addresses: Drs. Strober, Ludviksson, and Fuss: Mucosal Immunity Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11N-238, Bethesda, MD 20892.
This article has been cited by other articles:
|
|
 |
|
  G. H. Stummvoll, R. J. DiPaolo, E. N. Huter, T. S. Davidson, D. Glass, J. M. Ward, and E. M. Shevach Th1, Th2, and Th17 Effector T Cell-Induced Autoimmune Gastritis Differs in Pathological Pattern and in Susceptibility to Suppression by Regulatory T Cells J. Immunol., August 1, 2008; 181(3): 1908 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kikuchi, C. L. Hahn, S. Tanaka, S. E. Barbour, H. A. Schenkein, and J. G. Tew Dendritic Cells Stimulated with Actinobacillus actinomycetemcomitans Elicit Rapid Gamma Interferon Responses by Natural Killer Cells Infect. Immun., September 1, 2004; 72(9): 5089 - 5096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T G Moreels, R J Nieuwendijk, J G De Man, B Y De Winter, A G Herman, E A Van Marck, and P A Pelckmans Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats Gut, January 1, 2004; 53(1): 99 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Pavan, P. Desreumaux, and A. Mercenier Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid Bacteria Clin. Vaccine Immunol., July 1, 2003; 10(4): 696 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Schreiber, P Rosenstiel, J Hampe, S Nikolaus, B Groessner, A Schottelius, T Kuhbacher, J Hamling, U R Folsch, and D Seegert Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease Gut, September 1, 2002; 51(3): 379 - 385. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Nakase, K. Okazaki, Y. Tabata, M. Ozeki, N. Watanabe, M. Ohana, S. Uose, K. Uchida, T. Nishi, M. Mastuura, et al. New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 59 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Hendrickson, R. Gokhale, and J. H. Cho Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease Clin. Microbiol. Rev., January 1, 2002; 15(1): 79 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Laroux, K. P. Pavlick, R. E. Wolf, and M. B. Grisham Dysregulation of Intestinal Mucosal Immunity: Implications in Inflammatory Bowel Disease Physiology, December 1, 2001; 16(6): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yoshida, T. Watanabe, T. Usui, Y. Matsunaga, Y. Shirai, M. Yamori, T. Itoh, S. Habu, T. Chiba, T. Kita, et al. CD4 T cells monospecific to ovalbumin produced by Escherichia coli can induce colitis upon transfer to BALB/c and SCID mice Int. Immunol., December 1, 2001; 13(12): 1561 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Trobonjaca, F. Leithauser, P. Moller, H. Bluethmann, Y. Koezuka, H. R. MacDonald, and J. Reimann MHC-II-Independent CD4+ T Cells Induce Colitis in Immunodeficient RAG-/- Hosts J. Immunol., March 15, 2001; 166(6): 3804 - 3812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Yoo, W. Lo, S. Goodman, W. Ali, C. Semrad, and M. Field Interferon-gamma downregulates ion transport in murine small intestine cultured in vitro Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1323 - G1332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Robinson, P. C. Okhuysen, C. L. Chappell, D. E. Lewis, I. Shahab, S. Lahoti, and A. C. White Jr. Transforming Growth Factor beta 1 Is Expressed in the Jejunum after Experimental Cryptosporidium parvum Infection in Humans Infect. Immun., September 1, 2000; 68(9): 5405 - 5407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kitani, I. J. Fuss, K. Nakamura, O. M. Schwartz, T. Usui, and W. Strober Treatment of Experimental (Trinitrobenzene Sulfonic Acid) Colitis by Intranasal Administration of Transforming Growth Factor (TGF)-{beta}1 Plasmid: TGF-{beta}1-mediated Suppression of T Helper Cell Type 1 Response Occurs by Interleukin (IL)-10 Induction and IL-12 Receptor {beta}2 Chain Downregulation J. Exp. Med., June 26, 2000; 192(1): 41 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Andres, P. L. Beck, E. Mizoguchi, A. Mizoguchi, A. K. Bhan, T. Dawson, W. A. Kuziel, N. Maeda, R. P. MacDermott, D. K. Podolsky, et al. Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine J. Immunol., June 15, 2000; 164(12): 6303 - 6312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Slonim, L. Bulone, M. B. Damore, T. Goldberg, M. A. Wingertzahn, and M. J. McKinley A Preliminary Study of Growth Hormone Therapy for Crohn's Disease N. Engl. J. Med., June 1, 2000; 342(22): 1633 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kawachi, S. Jennings, J. Panes, A. Cockrell, F. S. Laroux, L. Gray, M. Perry, H. van der Heyde, E. Balish, D. N. Granger, et al. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G734 - G743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Boushey, B. Yusta, and D. J. Drucker Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E937 - E947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A J S MACPHERSON, K J MALOY, and I BJARNASON Intolerance of the dirty intestine Gut, June 1, 1999; 44(6): 774 - 775. [Full Text]
|
|
|
|
|
|
T. T. Pizarro, M. H. Michie, M. Bentz, J. Woraratanadharm, M. F. Smith Jr., E. Foley, C. A. Moskaluk, S. J. Bickston, and F. Cominelli IL-18, a Novel Immunoregulatory Cytokine, Is Up-Regulated in Crohn's Disease: Expression and Localization in Intestinal Mucosal Cells J. Immunol., June 1, 1999; 162(11): 6829 - 6835. [Abstract] [Full Text] [PDF]
|
|
Article
